β-adrenergic stimulation modulates the sodium current block by propafenone in rat ventricular myocardium

Journal of Electrocardiology

Volumn 35, Issue 4, 2002, Pages 343-349

  Maier, Sebastian K G ^a   Kirstein, Michael ^a,b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b KLINIKUM SAARBRÜCKEN   (Germany)

Author keywords

Heart; Loose patch clamp; Propafenone; Sodium current; adrenergic regulation

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISOPRENALINE; PROPAFENONE;

ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENTIATION; FEMALE; HEART PAPILLARY MUSCLE; HEART VENTRICLE WALL; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM CURRENT; SYMPATHETIC TONE;

EID: 0036803185     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1054/jelc.2002.35849     Document Type: Article

References (27)

1. Vaughan Williams EM: A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 24:129, 1984
2. Kohlhardt M, Seifert C: Inhibition of Vmax of the action potential by propafenone and its voltage-, time- and pH-dependence in mammalian ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol 315:55, 1980
3. Kohlhardt M, Seifert C, Hondeghem LM: Tonic and phasic INa blockade by antiarrhythmics. Different properties of drug binding to fast sodium channels as judged from Vmax studies with propafenone and derivatives in mammalian ventricular myocardium. Pflügers Arch 396:199, 1983
4. Weirich J, Antoni H: Differential analysis of the frequency-dependent effects of class 1 antiarrhythmic drugs according to periodical ligand binding: Implications for antiarrhythmic and proarrhythmic efficacy. J Cardiovasc Pharmacol 15:998, 1990
5. Burnett DM, Gal J, Zahniser NR, Nies AS: Propafenone interacts stereoselectively with beta 1-and beta 2-adrenergic receptors. J Cardiovasc Pharmacol 12:615, 1988
6. Kroemer HK, Funck-Brentano C, Silberstein DJ, et al: Stereoselective disposition and pharmacologic activity of propafenone enantiomers. Circulation 79:1068, 1989
7. Ledda F, Mantelli L, Manzini S, et al: Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac preparations. J Cardiovasc Pharmacol 3:1162, 1981
8. Lee JT, Kroemer HK, Silberstein DJ, et al: The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone. N Engl J Med 322:1764, 1990
9. McLeod AA, Stiles GL, Shand DG: Demonstration of β-adrenoceptor blockade by propafenone hydrochloride: Clinical pharmacologic, radioligand binding and adenylate cyclase activation studies. J Pharmacol Exp Ther 228:461, 1984
10. Drici MD, Sbirrazzuoli V, Garraffo R, et al: Effect of propafenone hydrochloride on lymphocyte membrane beta 2 adrenoceptors in ventricular arrhythmias. Am J Cardiol 64:671, 1989
11. Paietta E, Poch G, Kukovetz WR: Analyse der Beta-Blocker Wirkung von Propafenon (SA79). 20-28, Fischer, Stuttgart, Hochrein H., Hapke H. J., and Beck OA.
12. Dukes ID, Vaughan Williams EM: The multiple modes of action of propafenone. Eur Heart J 5:115, 1984
13. von Philipsborn G, Gries J, Hofmann HP, et al: Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone. Arzneimittelforschung 34:1489, 1984
14. Kirstein M, Eickhorn R, Kochsiek K, et al: Dose-dependent alteration of rat cardiac sodium current by isoproterenol: Results from direct measurements on multicellular preparations. Pflügers Arch 431:395, 1996
15. Matsuda JJ, Lee H, Shibata EF: Enhancement of rabbit cardiac sodium channels by β-adrenergic stimulation. Circr Res 70:199, 1992
16. Ono K, Kiyosue T, Arita M: Isoproterenol, DBcAMP, and forskolin inhibit cardiac sodium current. Am J Physiol 256:1131, 1989
17. Schubert B, VanDongen AM Jr, Kirsch GE, et al: Inhibition of cardiac Na currents by isoproterenol. Am J Physiol 258:H977, 1991
18. Ono K, Fozzard HA, Hanck DA: Mechanism of cAMP-dependent modulation of cardiac sodium channel current kinetics. Circ Res 72:807, 1993
19. Malfatto G, Pessano P, Zaza A, et al: Experimental evidence for β-adrenergic blocking properties of propafenone and for their potential clinical relevance. Eur Heart J 14:1253, 1993
20. Antoni H, Bocker D, Eickhorn R: Sodium current kinetics in intact rat papillary muscle: Measurements with the loose-patch-clamp technique. J Physiol (Lond) 406, 199, 1988
21. Armstrong CM, Benzanilla F: Charge movement associated with the opening and closing of the activation gates of the Na channels. J Gen Physiol 63:533, 1974
22. Bevington PR: Data Reduction and Error Analysis for the Physical Sciences. New York, McGraw Hill, 1669, p. 204
23. Bryson HM, Palmer KJ, Langtry HD, et al: Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias. Drugs 45:85, 1993
24. Honjo H, Watanabe T, Kamiya K, et al: Effects of propafenone on electrical and mechanical activities of single ventricular myocytes isolated from guineapig hearts. Br J Pharmacol 97:731, 1989
25. Winslow E, Campbell JK: Comparative frequency-dependent effects of three class Ic agents. Org 7797, flecainide, and propafenone, on ventricular action potential duration. J Cardiovasc Pharmacol 18:911, 1991
26. Zipes DP: Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation 82:1095, 1990
27. + currents by isoproterenol. Am J Physiol 258:H977, 1990